Although further studies are warranted to clarify the causal relationship, our results suggest that the AGER rs2070600 polymorphism is a potential genetic marker for tumor-related inflammatory conditions and a poor prognosis in patients with metastatic lung adenocarcinoma. The gene discussed is AGER; the disease is neoplasm.